HUE063581T2 - Aeroszol pirfenidon és piridon analóg vegyületek - Google Patents

Aeroszol pirfenidon és piridon analóg vegyületek

Info

Publication number
HUE063581T2
HUE063581T2 HUE13822166A HUE13822166A HUE063581T2 HU E063581 T2 HUE063581 T2 HU E063581T2 HU E13822166 A HUE13822166 A HU E13822166A HU E13822166 A HUE13822166 A HU E13822166A HU E063581 T2 HUE063581 T2 HU E063581T2
Authority
HU
Hungary
Prior art keywords
pyridone analog
analog compounds
aerosol pirfenidone
pirfenidone
aerosol
Prior art date
Application number
HUE13822166A
Other languages
English (en)
Hungarian (hu)
Inventor
Mark Surber
Original Assignee
Avalyn Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avalyn Pharma Inc filed Critical Avalyn Pharma Inc
Publication of HUE063581T2 publication Critical patent/HUE063581T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HUE13822166A 2012-07-24 2013-07-24 Aeroszol pirfenidon és piridon analóg vegyületek HUE063581T2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261675286P 2012-07-24 2012-07-24
US201361756983P 2013-01-25 2013-01-25
US201361824818P 2013-05-17 2013-05-17

Publications (1)

Publication Number Publication Date
HUE063581T2 true HUE063581T2 (hu) 2024-01-28

Family

ID=49997965

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13822166A HUE063581T2 (hu) 2012-07-24 2013-07-24 Aeroszol pirfenidon és piridon analóg vegyületek

Country Status (8)

Country Link
EP (1) EP2877164B1 (enExample)
JP (5) JP6501264B2 (enExample)
AU (5) AU2013295800A1 (enExample)
CA (1) CA2880011C (enExample)
ES (1) ES2959198T3 (enExample)
HU (1) HUE063581T2 (enExample)
NZ (1) NZ705260A (enExample)
WO (1) WO2014018668A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
HUE058753T2 (hu) 2011-01-31 2022-09-28 Avalyn Pharma Inc Aeroszol formájú pirfenidon- és piridon-analóg vegyületek és alkalmazásaik
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CA3280124A1 (en) 2013-07-31 2025-10-31 Avalyn Pharma Inc. Aerosol imatinib compounds and uses thereof
JP7066321B2 (ja) 2014-01-10 2022-05-13 アヴァリン ファーマ インク． エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
IL295472B2 (en) * 2016-03-28 2024-10-01 Presage Biosciences Inc Pharmaceutical combinations for the treatment of cancer
US10238821B2 (en) * 2016-10-11 2019-03-26 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
WO2018234527A1 (en) * 2017-06-22 2018-12-27 Softhale Nv PIRFENIDONE AEROSOL ADMINISTRATION
US12048801B2 (en) 2017-06-22 2024-07-30 Invox Belgium Nv Aerosol delivery of pirfenidone
GB201807050D0 (en) * 2018-04-30 2018-06-13 Cellprotect Nordic Pharmaceuticals Ab Medical uses
WO2020219168A1 (en) 2019-04-24 2020-10-29 Convergene, Llc Small molecule bromodomain inhibitors and uses thereof
KR102847500B1 (ko) * 2019-05-27 2025-08-20 디에스엠 아이피 어셋츠 비.브이. 인 화합물 및 유기 황 화합물의 존재 하에서의 알킨의 알켄으로의 선택적 수소화
JP7490813B2 (ja) * 2020-04-22 2024-05-27 ユンジン ファーム．カンパニー、リミテッド 安全性と安定性が改善されたピルフェニドンを含む腸溶性製剤およびその製造方法
AU2021396535A1 (en) * 2020-12-07 2023-06-22 Mannkind Corporation Method and composition for treating pulmonary fibrosis
US12508228B2 (en) * 2022-03-30 2025-12-30 The Chinese University Of Hong Kong PFD loaded microspheres and method for preparing injectable composite microsphere hydrogel solution from same
CN115970069B (zh) * 2022-12-13 2024-09-24 南通大学附属医院 载吡非尼酮纳米粒子复合涂层输尿管支架管的制备方法
CN119548479A (zh) * 2024-12-31 2025-03-04 延边大学 一种吸入用吡非尼酮溶液及其使用方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826255A (en) 1972-06-22 1974-07-30 Hudson Oxygen Therapy Sales Co Intermittent positive pressure breathing manifold
YU41046B (en) 1974-08-22 1986-10-31 Schering Ag Medicine inholating device
ZA757570B (en) 1974-12-09 1977-07-27 Affiliated Med Res A useful n-substituted pyridone
US4268460A (en) 1977-12-12 1981-05-19 Warner-Lambert Company Nebulizer
US4253468A (en) 1978-08-14 1981-03-03 Steven Lehmbeck Nebulizer attachment
US4263907A (en) 1979-05-14 1981-04-28 Lindsey Joseph W Respirator nebulizer
US4510929A (en) 1982-04-30 1985-04-16 Bordoni Maurice E Disposable radioactive aerosol inhalation apparatus
US4649911A (en) 1983-09-08 1987-03-17 Baylor College Of Medicine Small particle aerosol generator for treatment of respiratory disease including the lungs
US4624251A (en) 1984-09-13 1986-11-25 Riker Laboratories, Inc. Apparatus for administering a nebulized substance
US5152456A (en) 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
US5164740A (en) 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
DE59108798D1 (de) 1991-11-07 1997-08-28 Ritzau Pari Werk Gmbh Paul Vernebler insbesondere zur Anwendung in Geräten für die Inhalationstherapie
EP0615470B1 (en) 1991-12-04 1995-12-13 The Technology Partnership Public Limited Company Fluid droplet production apparatus and method
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5709202A (en) 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
AU4990696A (en) 1995-02-24 1996-09-11 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
US5586550A (en) 1995-08-31 1996-12-24 Fluid Propulsion Technologies, Inc. Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
US6427682B1 (en) 1995-04-05 2002-08-06 Aerogen, Inc. Methods and apparatus for aerosolizing a substance
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6083922A (en) 1996-04-02 2000-07-04 Pathogenesis, Corp. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
US5906202A (en) 1996-11-21 1999-05-25 Aradigm Corporation Device and method for directing aerosolized mist to a specific area of the respiratory tract
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
DE19713636A1 (de) 1997-04-02 1998-10-08 Pari Gmbh Atemzugsimulator
US5855564A (en) 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism
JP2001518494A (ja) 1997-10-08 2001-10-16 セプレイサー インコーポレイテッド エアゾル投与用の投薬形態
DK1129741T3 (da) 1997-11-19 2006-08-07 Microflow Eng Sa Forstövningsindretning til inhalator
US6192876B1 (en) 1997-12-12 2001-02-27 Astra Aktiebolag Inhalation apparatus and method
WO2000016775A1 (en) 1998-09-18 2000-03-30 Mepha Ag Topical formulation of alkyl-, phenyl-pyridone
GB2343122B (en) 1998-10-26 2003-01-08 Medic Aid Ltd Improvements in and relating to nebulisers
US6070575A (en) 1998-11-16 2000-06-06 Aradigm Corporation Aerosol-forming porous membrane with certain pore structure
US6584971B1 (en) 1999-01-04 2003-07-01 Medic-Aid Limited Drug delivery apparatus
US6338443B1 (en) 1999-06-18 2002-01-15 Mercury Enterprises, Inc. High efficiency medical nebulizer
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
CA2826724C (en) 2000-04-11 2016-02-02 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
US6601581B1 (en) 2000-11-01 2003-08-05 Advanced Medical Applications, Inc. Method and device for ultrasound drug delivery
DE10102846B4 (de) 2001-01-23 2012-04-12 Pari Pharma Gmbh Aerosolgenerator
ATE298600T1 (de) 2001-10-18 2005-07-15 Pari Gmbh Inhalationstherapievorrichtung
ATE269735T1 (de) 2001-10-18 2004-07-15 Pari Gmbh Inhalationstherapievorrichtung
JP2005508220A (ja) 2001-10-24 2005-03-31 パーリ・ゲーエムベーハー 薬用組成物調製用具
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
JP4542743B2 (ja) 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CA2693771A1 (en) * 2007-07-13 2009-01-22 Abbott Biotechnology Ltd. Methods and compositions for pulmonary administration of a tnf.alpha. inhibitor
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
AU2009302478B2 (en) * 2008-10-07 2015-09-03 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
AU2010302420B2 (en) * 2009-10-02 2013-07-04 Astrazeneca Ab 2-pyridone compounds used as inhibitors of neutrophil elastase
JP6239054B2 (ja) * 2010-11-26 2017-11-29 東芝メディカルシステムズ株式会社 磁気共鳴診断装置
HUE058753T2 (hu) * 2011-01-31 2022-09-28 Avalyn Pharma Inc Aeroszol formájú pirfenidon- és piridon-analóg vegyületek és alkalmazásaik

Also Published As

Publication number Publication date
JP7120984B2 (ja) 2022-08-17
AU2020201557B2 (en) 2022-08-25
WO2014018668A2 (en) 2014-01-30
AU2013295800A1 (en) 2015-03-19
CA2880011A1 (en) 2014-01-30
AU2020201557A1 (en) 2020-03-26
JP2022078126A (ja) 2022-05-24
EP2877164C0 (en) 2023-07-05
JP6501264B2 (ja) 2019-04-17
JP2015523395A (ja) 2015-08-13
AU2018206852A1 (en) 2018-08-09
JP2024095678A (ja) 2024-07-10
WO2014018668A3 (en) 2014-10-16
AU2024267029A1 (en) 2024-12-19
CA2880011C (en) 2021-02-16
EP2877164B1 (en) 2023-07-05
EP2877164A4 (en) 2016-01-13
EP2877164A2 (en) 2015-06-03
JP2018172402A (ja) 2018-11-08
JP2020073494A (ja) 2020-05-14
AU2022271417A1 (en) 2022-12-22
ES2959198T3 (es) 2024-02-21
NZ705260A (en) 2017-04-28
HK1210955A1 (en) 2016-05-13

Similar Documents

Publication Publication Date Title
IL274988A (en) Carbamoylpyridone-polycyclic compounds and their pharmaceutical use
HUE058753T2 (hu) Aeroszol formájú pirfenidon- és piridon-analóg vegyületek és alkalmazásaik
EP2877164C0 (en) Aerosol pirfenidone and pyridone analog compounds
EP3091976A4 (en) Aerosol pirfenidone and pyridone analog compounds and uses thereof
IL236036A0 (en) Pyridinone and pyridizinone derivatives
ZA201405486B (en) Pyridone derivatives
DK2903991T3 (da) Anti-fibrotiske pyridinoner
IL235734B (en) Process for the preparation of treprostinil and derivatives thereof
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
GB201502602D0 (en) Aerosol actuators, devices and methods of making and using the same
IL229963A0 (en) Substituted quinolines and their use as medicaments
PL2842945T3 (pl) Pochodna sulfonamidowa i jej zastosowanie medyczne
IL251974B (en) Antifibrosis compounds and their uses
HUE036280T2 (hu) Vortioxetint és donepezilt tartalmazó készítmények
ZA201504167B (en) Processes for the preparation of 4-amino-3-halo-6- (substituted)picolinates and 4-amino-5-fluoro-3-halo-6- (substituted)picolinates
HUE038523T2 (hu) Piridon-származék és ezt tartalmazó gyógyszerkészítmény
DE112013005459A5 (de) Aerosol-Sprühsystem
TH1301004812B (th) ผลิตภัณฑ์ซึมซับและวิธีการผลิต